SEARCH

SEARCH BY CITATION

References

  • Acarin L., Gonzalez B. and Castellano B. (2002) Decrease of proinflammatory molecules correlates with neuroprotective effect of the fluorinated salicylate triflusal after postnatal excitotoxic damage. Stroke 33, 24992505.
  • Alderton W. K., Cooper C. E. and Knowles R. G. (2001) Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357, 593615.
  • Almer G., Vukosavic S., Romero N. and Przedborski S. (1999) Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 72, 24152425.
  • Bacman S. R., Bradley W. G. and Moraes C. T. (2006) Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target? Mol. Neurobiol. 33, 113131.
  • Barsacchi R., Perrotta C., Sestili P., Cantoni O., Moncada S. and Clementi E. (2002) Cyclic GMP-dependent inhibition of acid sphingomyelinase by nitric oxide: an early step in protection against apoptosis. Cell Death Differ. 9, 12481255.
  • Bo L., Dawson T. M., Wesselingh S., Mork S., Choi S., Kong P. A., Hanley D. and Trapp B. D. (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36, 778786.
  • Boulton C. L., Southam E. and Garthwaite J. (1995) Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience 69, 699703.
  • Bove K., Neumann P., Gertzberg N. and Johnson A. (2001) Role of ecNOS-derived NO in mediating TNF-induced endothelial barrier dysfunction. Am. J. Physiol. Lung Cell Mol. Physiol. 280, L914L922.
  • Bruijn L. I., Miller T. M. and Cleveland D. W. (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27, 723749.
  • Buccoliero R. and Futerman A. H. (2003) The roles of ceramide and complex sphingolipids in neuronal cell function. Pharmacol. Res. 47, 409419.
  • Bulotta S., Barsacchi R., Rotiroti D., Borgese N. and Clementi E. (2001) Activation of the endothelial nitric-oxide synthase by tumor necrosis factor-alpha. A novel feedback mechanism regulating cell death. J. Biol. Chem. 276, 65296536.
  • Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D. A. and Giuffrida Stella A. M. (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 8, 766775.
  • Carlson N. G., Wieggel W. A., Chen J., Bacchi A., Rogers S. W. and Gahring L. C. (1999) Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J. Immunol. 163, 39633968.
  • Chen J., Zacharek A., Zhang C., Jiang H., Li Y., Roberts C., Lu M., Kapke A. and Chopp M. (2005) Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J. Neurosci. 25, 23662375.
  • Clementi E., Sciorati C. and Nistico G. (1995) Growth factor-induced Ca2+ responses are differentially modulated by nitric oxide via activation of a cyclic GMP-dependent pathway. Mol. Pharmacol. 48, 10681077.
  • Clementi E., Brown G. C., Feelisch M. and Moncada S. (1998) Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc. Natl Acad. Sci. USA 95, 76317636.
  • De Nadai C., Sestili P., Cantoni O., Lievremont J. P., Sciorati C., Barsacchi R., Moncada S., Meldolesi J. and Clementi E. (2000) Nitric oxide inhibits tumor necrosis factor-alpha-induced apoptosis by reducing the generation of ceramide. Proc. Natl Acad. Sci. USA 97, 54805485.
  • De Palma C., Meacci E., Perrotta C., Bruni P. and Clementi E. (2006) Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium. Arterioscler. Thromb. Vasc. Biol. 26, 99105.
  • Deniaud A., Sharaf El Dein O., Maillier E., Poncet D., Kroemer G., Lemaire C. and Brenner C. (2008) Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene 27, 285299.
  • Dudzinski D. M. and Michel T. (2007) Life history of eNOS: partners and pathways. Cardiovasc. Res. 75, 247260.
  • Ebadi M. and Sharma S. K. (2003) Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson’s disease. Antioxid. Redox Signal. 5, 319335.
  • Estrada C. and Murillo-Carretero M. (2005) Nitric oxide and adult neurogenesis in health and disease. Neuroscientist 11, 294307.
  • Fiorucci S., Antonelli E., Santucci L., Morelli O., Miglietti M., Federici B., Mannucci R., Del Soldato P. and Morelli A. (1999) Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology 116, 10891106.
  • Fulton D., Gratton J. P. and Sessa W. C. (2001) Post-translational control of endothelial nitric oxide synthase: why isn’t calcium/calmodulin enough? J. Pharmacol. Exp. Ther. 299, 818824.
  • Garthwaite J. and Boulton C. L. (1995) Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57, 683706.
  • Garthwaite G., Bartus K., Malcolm D., Goodwin D., Kollb-Sielecka M., Dooldeniya C. and Garthwaite J. (2006) Signaling from blood vessels to CNS axons through nitric oxide. J. Neurosci. 26, 77307740.
  • Ghezzi P. and Mennini T. (2001) Tumor necrosis factor and motoneuronal degeneration: an open problem. Neuroimmunomodulation 9, 178182.
  • Gibbs S. M. (2003) Regulation of neuronal proliferation and differentiation by nitric oxide. Mol. Neurobiol. 27, 107120.
  • Goligorsky M. S., Li H., Brodsky S. and Chen J. (2002) Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. Am. J. Physiol. Renal Physiol. 283, F1F10.
  • Gonzalez de Aguilar J. L., Gordon J. W., Rene F., De Tapia M., Lutz-Bucher B., Gaiddon C. and Loeffler J. P. (2000) Alteration of the Bcl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: evidence for the implication of the p53 signaling pathway. Neurobiol. Dis. 7, 406415.
  • Gould T. W., Buss R. R., Vinsant S., Prevette D., Sun W., Knudson C. M., Milligan C. E. and Oppenheim R. W. (2006) Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 26, 87748786.
  • Hadano S., Hand C. K., Osuga H. et al. (2001) A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 29, 166173.
  • Hadano S., Kunita R., Otomo A., Suzuki-Utsunomiya K. and Ikeda J. E. (2007) Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration. Neurochem. Int. 51, 7484.
  • Hardingham G. E. and Bading H. (2003) The Yin and Yang of NMDA receptor signalling. Trends Neurosci. 26, 8189.
  • He B. P., Wen W. and Strong M. J. (2002) Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro. J. Neuroimmunol. 128, 3138.
  • Heneka M. T. and Feinstein D. L. (2001) Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 114, 818.
  • Iravani M. M., Kashefi K., Mander P., Rose S. and Jenner P. (2002) Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. Neuroscience 110, 4958.
  • Ischiropoulos H. and Beckman J. S. (2003) Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J. Clin. Invest. 111, 163169.
  • Jaffrey S. R. and Snyder S. H. (1995) Nitric oxide: a neural messenger. Annu. Rev. Cell Dev. Biol. 11, 417440.
  • Kashiwado K., Yoshiyama Y., Arai K. and Hattori T. (2002) Expression of nitric oxide synthases in the anterior horn cells of amyotrophic lateral sclerosis. Prog. Neuropsychopharmacol. Biol. Psychiatry 26, 163167.
  • Kim Y. M., Kim T. H., Seol D. W., Talanian R. V. and Billiar T. R. (1998) Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. J. Biol. Chem. 273, 3143731441.
  • Kone B. C., Kuncewicz T., Zhang W. and Yu Z. Y. (2003) Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. Am. J. Physiol. Renal Physiol. 285, F178F190.
  • Kostic V., Jackson-Lewis V., De Bilbao F., Dubois-Dauphin M. and Przedborski S. (1997) Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277, 559562.
  • Kruman I. I. , Wersto R. P., Cardozo-Pelaez F., Smilenov L., Chan S. L., Chrest F. J., Emokpae Jr R., Gorospe M. and Mattson M. P. (2004) Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 41, 549561.
  • Leker R. R., Teichner A., Ovadia H., Keshet E., Reinherz E. and Ben-Hur T. (2001) Expression of endothelial nitric oxide synthase in the ischemic penumbra: relationship to expression of neuronal nitric oxide synthase and vascular endothelial growth factor. Brain Res. 909, 17.
  • Levy D., Tal M., Hoke A. and Zochodne D. W. (2000) Transient action of the endothelial constitutive nitric oxide synthase (ecNOS) mediates the development of thermal hypersensitivity following peripheral nerve injury. Eur. J. Neurosci. 12, 23232332.
  • Li B., Xu W., Luo C., Gozal D. and Liu R. (2003) VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. Brain Res. Mol. Brain Res. 111, 155164.
  • Liu L. and Stamler J. S. (1999) NO: an inhibitor of cell death. Cell Death Differ. 6, 937942.
  • MacGowan D. J., Scelsa S. N. and Waldron M. (2001) An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 57, 10941097.
  • Marchetti L., Klein M., Schlett K., Pfizenmaier K. and Eisel U. L. (2004) Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J. Biol. Chem. 279, 3286932881.
  • Martin L. J., Chen K. and Liu Z. (2005) Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation. J. Neurosci. 25, 64496459.
  • McGuire V., Longstreth Jr W. T., Koepsell T. D. and Van Belle G. (1996) Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 47, 571573.
  • Moncada S. and Bolanos J. P. (2006) Nitric oxide, cell bioenergetics and neurodegeneration. J. Neurochem. 97, 16761689.
  • De La Monte S. M., Lu B. X., Sohn Y. K., Etienne D., Kraft J., Ganju N. and Wands J. R. (2000) Aberrant expression of nitric oxide synthase III in Alzheimer’s disease: relevance to cerebral vasculopathy and neurodegeneration. Neurobiol. Aging 21, 309319.
  • Moreau C., Devos D., Brunaud-Danel V., Defebvre L., Perez T., Destee A., Tonnel A. B., Lassalle P. and Just N. (2005) Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia? Neurology 65, 19581960.
  • Mu X., He J., Anderson D. W., Trojanowski J. Q. and Springer J. E. (1996) Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann. Neurol. 40, 379386.
  • Nixon R. A. (2005) Endosome function and dysfunction in Alzheimer’s disease and other neurodegenerative diseases. Neurobiol. Aging 26, 373382.
  • Opel D., Poremba C., Simon T., Debatin K. M. and Fulda S. (2007) Activation of Akt predicts poor outcome in neuroblastoma. Cancer Res. 67, 735745.
  • Panzeri C., De Palma C., Martinuzzi A., Daga A., De Polo G., Bresolin N., Miller C. C., Tudor E. L., Clementi E. and Bassi M. T. (2006) The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function. Brain 129, 17101719.
  • Pardo A. C., Wong V., Benson L. M., Dykes M., Tanaka K., Rothstein J. D. and Maragakis N. J. (2006) Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice. Exp. Neurol. 201, 120130.
  • Pasinelli P. and Brown R. H. (2006) Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7, 710723.
  • Pereira de Vasconcelos A., Riban V., Wasterlain C. and Nehlig A. (2006) Role of endothelial nitric oxide synthase in cerebral blood flow changes during kainate seizures: a genetic approach using knockout mice. Neurobiol. Dis. 23, 219227.
  • Pitson S. M., Moretti P. A., Zebol J. R., Xia P., Gamble J. R., Vadas M. A., D’Andrea R. J. and Wattenberg B. W. (2000) Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation. A dominant-negative sphingosine kinase. J. Biol. Chem. 275, 3394533950.
  • Potashkin J. A. and Meredith G. E. (2006) The role of oxidative stress in the dysregulation of gene expression and protein metabolism in neurodegenerative disease. Antioxid. Redox Signal. 8, 144151.
  • Raoul C., Buhler E., Sadeghi C., Jacquier A., Aebischer P., Pettmann B., Henderson C. E. and Haase G. (2006) Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL. Proc. Natl Acad. Sci. USA 103, 60076012.
  • Reif A., Schmitt A., Fritzen S. et al. (2004) Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour. Eur. J. Neurosci. 20, 885895.
  • Robertson J., Beaulieu J. M., Doroudchi M. M., Durham H. D., Julien J. P. and Mushynski W. E. (2001) Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-alpha. J. Cell Biol. 155, 217226.
  • Sciorati C., Rovere P., Ferrarini M., Heltai S., Manfredi A. A. and Clementi E. (1997) Autocrine nitric oxide modulates CD95-induced apoptosis in gammadelta T lymphocytes. J. Biol. Chem. 272, 2321123215.
  • Sciorati C., Galvez B. G., Brunelli S., Tagliafico E., Ferrari S., Cossu G. and Clementi E. (2006) Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J. Cell Sci. 119, 51145123.
  • Shen Y. H., Wang X. L. and Wilcken D. E. (1998) Nitric oxide induces and inhibits apoptosis through different pathways. FEBS Lett. 433, 125131.
  • Sohn Y. K., Ganju N., Bloch K. D., Wands J. R. and De La Monte S. M. (1999) Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative diseases. J. Neurol. Sci. 162, 133151.
  • Steensma D. P., Timm M. and Witzig T. E. (2003) Flow cytometric methods for detection and quantification of apoptosis. Methods Mol. Med. 85, 323332.
  • Sud N., Wedgwood S. and Black S. M.(2008) Protein kinase δ regulates endothelial nitric oxide synthase expression via Akt activation and nitric oxide generaton. Am. J. Physiol. Lung Cell Mol. Physiol. published ahead of print, 11th January 2008
  • Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., Sonobe Y., Mizuno T. and Suzumura A. (2006) Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 281, 2136221368.
  • Turrin N. P. and Rivest S. (2006) Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. J. Neurosci. 26, 143151.
  • Van Den Bosch L., Van Damme P., Bogaert E. and Robberecht W. (2006) The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1762, 10681082.
  • Vodovotz Y., Lucia M. S., Flanders K. C. et al. (1996) Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer’s disease. J. Exp. Med. 184, 14251433.
  • Wilson R. I., Godecke A., Brown R. E., Schrader J. and Haas H. L. (1999) Mice deficient in endothelial nitric oxide synthase exhibit a selective deficit in hippocampal long-term potentiation. Neuroscience 90, 11571165.
  • Xu C., Bailly-Maitre B. and Reed J. C. (2005) Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115, 26562664.
  • Yoshizumi M., Perrella M. A., Burnett Jr J. C. and Lee M. E. (1993) Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73, 205209.